Back
iShares S&P Mid-Cap 400 Value ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
33
IJJ
iShares S&P Mid-Cap 400 Value ETF
Last Price:
112.88
Seasonality Move:
0.38%
Buy
53
SRPT
Sarepta Therapeutics
Last Price:
158.06
Seasonality Move:
18.65%
Sell
33
iShares S&P Mid-Cap 400 Value ETF (IJJ)
is a Sell
Is iShares S&P Mid-Cap 400 Value ETF a Buy, Sell or Hold?
- The current iShares S&P Mid-Cap 400 Value ETF [IJJ] share price is $112.50. The Score for IJJ is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- IJJ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
53
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $156.91. The Score for SRPT is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IJJ Stock Price Chart
What is iShares S&P Mid-Cap 400 Value ETF's stock price today?
-
The iShares S&P Mid-Cap 400 Value ETF share price today is $112.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IJJ is experiencing slight buying pressure.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $156.91
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
IJJ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.56 | Sell |
Relative Strength Index (14 RSI): | 43.33 | Sell |
Chaikin Money Flow: | 44087 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (112.72 - 115.44) | Sell |
Bollinger Bands (100): | (111.5 - 115.94) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 7.17 | Buy |
Relative Strength Index (14 RSI): | 68.43 | Buy |
Chaikin Money Flow: | 1613298 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (113.82 - 142.64) | Buy |
Bollinger Bands (100): | (118.8 - 136.1) | Buy |
IJJ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.82 | Sell |
20-day SMA: | 113.71 | Sell |
50-day SMA: | 113.95 | Sell |
200-day SMA: | 109.23 | Buy |
8-day EMA: | 113.02 | Sell |
20-day EMA: | 113.6 | Sell |
50-day EMA: | 113.95 | Sell |
200-day EMA: | 110.86 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 140.03 | Buy |
20-day SMA: | 129.22 | Buy |
50-day SMA: | 127.95 | Buy |
200-day SMA: | 115.45 | Buy |
8-day EMA: | 145.32 | Buy |
20-day EMA: | 134.79 | Buy |
50-day EMA: | 129.39 | Buy |
200-day EMA: | 120.67 | Buy |
iShares S&P Mid-Cap 400 Value ETF Earnings Growth & IJJ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
iShares S&P Mid-Cap 400 Value ETF Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 12 | Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
12 | 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |